Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Viva Gold Reports Multiple High-Grade Gold Hits at the Tonopah Gold Project (click to learn more) Xcyte Digital Corp. Signs Agreement to Purchase Assets of Webinar.net (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Avivagen Inc V.VIV

Alternate Symbol(s):  VIVXF

Healthcare
Avivagen Inc. is a Canada-based life sciences company. The Company is focused on developing and commercializing products for livestock, companion animal and human applications that safely enhances feed intake and supports immune function, thereby supporting general health and performance. The Company’s operations as one segment, products based on OxC-beta Technology. It OxC-beta technology is... see more

Recent & Breaking News (TSXV:VIV)

Avivagen Retains ITG to Conduct Market Making Activities

GlobeNewswire October 2, 2018

Avivagen Announces First Order for  OxC-beta™ Livestock in Thailand

GlobeNewswire September 26, 2018

Avivagen Announces its Attendance at BIOSPAIN 2018

GlobeNewswire September 24, 2018

Avivagen Announces Follow-On Large Order from UNAHCO for OxC-beta™ Livestock

GlobeNewswire September 20, 2018

Avivagen Announces Approval from TSX Venture Exchange for Extension of Warrants

GlobeNewswire September 17, 2018

Avivagen Announces Q3 Financial Results and Proposed Extension of Warrants

GlobeNewswire September 5, 2018

Avivagen Announces Vivamune Distribution Agreement for the GTA

GlobeNewswire August 22, 2018

Avivagen Announces Agreement to Terminate China JV

GlobeNewswire August 7, 2018

Avivagen Chairman and CEO Kym Anthony, Joins Everett Jolly Uptick Newswire’s “Stock Day” Podcast

GlobeNewswire July 17, 2018

Avivagen Receives Approval from Health Canada for Use of OxC-beta™ in Companion Animal Supplements

GlobeNewswire June 27, 2018

Avivagen Announces Largest Order To-Date for OxC-beta™ Livestock

GlobeNewswire June 25, 2018

Avivagen to Exhibit Vivamune at SuperZoo

GlobeNewswire June 22, 2018

Avivagen Announces Distribution Agreement in Thailand

GlobeNewswire June 13, 2018

Avivagen Announces Q2 Financial Results

GlobeNewswire June 5, 2018

Avivagen Announces Distribution in China for Vivamune

GlobeNewswire June 1, 2018

Avivagen Announces Approval of OxC-beta™ For Use in Livestock in New Zealand

GlobeNewswire May 30, 2018

Avivagen to Pursue Regulatory Approval in Mexico

GlobeNewswire May 25, 2018

Avivagen Announces the Issuance of Shares

GlobeNewswire May 2, 2018

Avivagen Announces its Attendance at the Bloom Burton & Co. Healthcare Investor Conference

GlobeNewswire May 1, 2018

Avivagen Announces the Issuance of Stock Options

GlobeNewswire April 13, 2018